Long-term efficacy and safety of oral calcium as compared to A1(OH)3 as phosphate binders.
Moriniere
P
P
Service d'Hemodialyse, Hôpital Sud, CHU Amiens, France.
Hocine
C
C
Boudailliez
B
B
Belbrik
S
S
Renaud
H
H
Westeel
P F
PF
Solal
M C
MC
Fournier
A
A
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000536:Aluminum Hydroxide / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001847:Bone Diseases / Q000139:chemically induced; D002114:Calcinosis / Q000139:chemically induced; D002118:Calcium / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008276:Magnesium Hydroxide / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000378:metabolism*; D013997:Time Factors
D010710:Phosphates; D000536:Aluminum Hydroxide; D008276:Magnesium Hydroxide; D002118:Calcium